MondegarAI
Whitefort Capital Management, LP

Q4 2024 · 13F-HR

Whitefort Capital Management, LPholdings as filed

Filed 2025-02-14 · accession 0001013594-25-000295

$209.0M
Reported value
18
Positions
2024-12-31
Period end
View analyzed profile →PRO

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
03879J100ABUSARBUTUS BIOPHARMA CORP$43.3M20.7%13,241,916CommonSOLE
G76279101ROIVROIVANT SCIENCES LTD$28.3M13.5%2,391,000CommonSOLE
53635D202LQDALIQUIDIA CORPORATION$23.4M11.2%1,987,245CommonSOLE
37247D106GNWGENWORTH FINL INC$20.9M9.99%2,986,960CommonSOLE
127537207CDZICADIZ INC$19.3M9.26%3,719,951CommonSOLE
46591M109JOYYJOYY INC$17.6M8.42%420,427CommonSOLE
29260Y1090C3ENDEAVOR GROUP HLDGS INC$15.6M7.49%500,000CommonSOLE
65345N106NNNEXTNAV INC$9.8M4.69%629,590CommonSOLE
Y27183600GSLGLOBAL SHIP LEASE INC NEW$8.1M3.86%369,768CommonSOLE
29664WAB1ESPR 4 11/15/25ESPERION THERPEUTICS INC NE$7.8M3.72%8,000,000CommonSOLE
78573NAE2SABHLD 4 04/15/25SABRE GLBL INC$4.9M2.36%5,000,000CommonSOLE
404139AG2VATE 7.5 08/01/26 *INNOVATE CORP$4.2M1.99%12,218,000CommonSOLE
G5753U1124OWAMAIDEN HOLDINGS LTD$3.4M1.62%1,997,005CommonSOLE
45784J303VATEINNOVATE CORP$1.6M0.76%320,131CommonSOLE
65345N114NNAVWNEXTNAV INC$579,0510.28%100,880CommonSOLE
68375N103OPKOPKO HEALTH INC$197,7000.09%134,490CommonSOLE
896438504TRIBTRINITY BIOTECH PLC$72,0900.03%81,902CommonSOLE
02157M116AEAEWALTENERGY ACQUISITION CORP$7830.00%186,315CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.